Public health and ethical considerations, re Covid-19 vaccinations

ASE made this Official Information request to Ministry of Health

Response to this request is delayed. By law, Ministry of Health should normally have responded promptly and by (details and exceptions)

From: ASE

Dear Ministry of Health,

Given that SARS-Cov-2, the virus that causes Covid-19 is prone to mutate, and given that leaky vaccines (such as current vaccines against SARS-Cov-2) are known to select for and promote vaccine restraint mutations/strains of viruses, and given that certain populations (eg young and healthy people) have very low risk of poor outcome from Covid-19, particularity the currently dominant B.1.617.2/Delta strain,

What public health and ethical considerations has The Ministry of Health evaluated in balancing (a) the wider promotion of a Covid-19/SARS-Cov-2 vaccine, which may be likely to produce more asymptomatic carriers and more vaccine resistant strains, against (b) limiting vaccine use for people who are at risk of poor outcome from Covid-19, due to age, obesity, or other well documented comorbidities which predict poor outcome from Covid-19?

eg, how has The Ministry of Health considered public health and ethical arguments against vaccinating people with very low risk of poor outcome from Covid-19, since both asymptomatic spread (exacerbated by vaccinated people not knowing they're contagious, and/or risk compensation of vaccinated people, among other factors) and vaccine resistant strains of SARS-Cov-2 may both likely be outcomes of wider promotion of Covid-19 vaccines, and lead to a worse public health outcome?

If The Ministry of Health has not evaluated this public health and ethical trade-off, then why were such public health and ethical considerations not accounted for?

Thank you for your time and attention,

A S Emet

Link to this

From: OIA Requests


Attachment image001.png
7K Download


Kia ora,

 

Thank you for your request for official information received on 18
September 2021 for:

 

"Given that SARS-Cov-2, the virus that causes Covid-19 is prone to mutate,
and given that leaky vaccines (such as current vaccines against
SARS-Cov-2) are known to select for and promote vaccine restraint
mutations/strains of viruses, and given that certain populations (eg young
and healthy people) have very low risk of poor outcome from Covid-19,
particularity the currently dominant B.1.617.2/Delta strain,

 

What public health and ethical considerations has The Ministry of Health
evaluated in balancing (a) the wider promotion of a Covid-19/SARS-Cov-2
vaccine, which may be likely to produce more asymptomatic carriers and
more vaccine resistant strains, against (b) limiting vaccine use for
people who are at risk of poor outcome from Covid-19, due to age, obesity,
or other well documented comorbidities which predict poor outcome from
Covid-19?

 

eg, how has The Ministry of Health considered public health and ethical
arguments against vaccinating people with very low risk of poor outcome
from Covid-19, since both asymptomatic spread (exacerbated by vaccinated
people not knowing they're contagious, and/or risk compensation of
vaccinated people, among other factors) and vaccine resistant strains of
SARS-Cov-2 may both likely be outcomes of wider promotion of Covid-19
vaccines, and lead to a worse public health outcome?

 

If The Ministry of Health has not evaluated this public health and ethical
trade-off, then why were such public health and ethical considerations not
accounted for?”

 

A secondary request for official information was received on 18 September
2021 for:

 

“What considerations has The Ministry of Health given to Covid-19
treatment protocols such as the FLCCC Alliance's MATH+, I-MASK+ and
I-RECOVER Protocols?

Considering the results of those FLCCC protocols, on what balance of
evidence are those protocols not being promoted as standard of care for
both the prevention and treatment of Covid-19 in New Zealand?”

 

The Ministry of Health has consolidated your requests and the reference
number for your request is: H202112576.

 

As required under the Official Information Act 1982, the Ministry will
endeavour to respond to your request no later than 15 October 2021, being
20 working days after the day your request was received.

 

Due to the COVID-19 global pandemic response, the Ministry is experiencing
significantly higher volumes of queries and requests for information. If
we are unable to respond to your request within this time frame, we will
notify you of an extension of that time frame.

 

If you have any queries related to this request, please do not hesitate to
get in touch.

 

Ngâ mihi

 

OIA Services

Government Services

Office of the Director-General

Ministry of Health

E: [1][email address]

 

show quoted sections

References

Visible links
1. mailto:[email address]

Link to this

Things to do with this request

Anyone:
Ministry of Health only: